Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Private Placement of Relmada Therapeutics, Inc.

NEW YORK, May 12, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Laidlaw & Company (UK) Ltd. as sole Placement Agent in a $10 million Private Placement offering for Relmada Therapeutics, Inc., a privately held company. The offering was of Units consisting of Common Stock and Class A and B Warrants. The Sichenzia Ross Friedman Ference LLP team was led by partners Richard Friedman and Stephen Cohen.
Media Contact:
pr@srf.law
212-930-9700
- Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $17.25 Million Initial Public Offering of Common Stock of Forza X1, Inc. - August 17, 2022
- Sichenzia Ross Ference LLP Joins Splash Beverage Group, Inc. in Ringing Opening Bell at NYSE - July 29, 2022
- Sichenzia Ross Ference LLP Represents Roth Capital Partners in Public Offering of Common Stock of Crown Electrokinetics Corp. - July 26, 2022